.png){kind=logo}
Global advancements in data science and artificial intelligence intertwine to unlock fascinating insights, driving innovation across industries. Analytics Insight recently spoke to Florent Hassen, the Global Data Science and Artificial Intelligence Lead at Roche Pharmaceuticals, during an engaging interview in which he discussed developing an AI-powered solution to enhance customer engagement. This solution will provide deep insights, informed decision-making, and measurable impact assessments.
Since joining Roche in 2019, he has focused on establishing the Global Commercial Advanced Analytics team. Over the years, his leadership has been key in advancing initiatives related to global data strategy, external data acquisition, and data partnerships.
Florent has built a foundation in data science and AI through various impactful roles during his illustrious career. His professional journey began at IMS Health (now IQVIA), where predictive models were developed while refining programming skills. During his nine-year tenure at IQVIA, Roche led numerous initiatives, including drug marketing strategies, sales force optimization, machine learning applications, and data quality improvements.
Transitioning to OpusLine (now part of Accenture) provided an opportunity to advise the French Ministry of Economy on AI and Big Data applications in Life Sciences. Additionally, significant contributions were made to restructuring a top pharmaceutical company's Global Insights & Analytics organization.
When entering the field in 2006, “Data Science” had yet to gain mainstream recognition. Early experiences involved encountering skepticism from business leaders reluctant to trust algorithm-driven insights. The contrast between initial industry perceptions and today’s widespread AI adoption highlights the evolving role of data science. Advocacy for advanced analytics and driving adoption have been central to demonstrating the value of data-driven decision-making.
Success in data science leadership requires translating complex analytics into actionable business insights. A strong emphasis is placed on bridging the gap between technical teams and business stakeholders. The ability to understand intricate data science topics while effectively communicating findings ensures that AI-driven solutions align with strategic objectives.
Balancing technical expertise with business acumen enables the development of innovative solutions that drive meaningful impact within an organization.
True innovation requires distinguishing between stakeholders' immediate wants and their deeper needs. Developing effective AI-powered solutions involves integrating UX Research and UX Design methodologies. AI applications become more impactful and sustainable by understanding user behavior, challenges, and aspirations.
Focusing on delivering long-term value rather than short-term fixes ensures that Roche’s AI initiatives remain at the forefront of industry advancements.
The last decade has brought a paradigm shift in data-driven innovation, with AI, Big Data, and Cloud Computing transforming the industry. The rise of specialized roles such as DevOps, DataOps, MLOps, and Cloud Engineers reflects the increasing complexity of this ecosystem. Cross-functional collaboration is now essential, as no single expert can master every aspect of this rapidly evolving field.
Aspiring data science leaders are encouraged to embrace the trade-off between technical expertise and leadership responsibilities. As careers progress, the focus naturally shifts toward strategic decision-making and stakeholder management. Although this transition may reduce hands-on technical involvement, the ability to drive AI adoption at an enterprise level remains a crucial skill for industry leaders.
Roche Pharmaceuticals has solidified its position as a leader in AI adoption, ranking #1 in the Index of AI Readiness among major pharmaceutical companies. Under the leadership of the Global Data Science & AI Lead, the company continues embedding AI and data science at the core of its strategic initiatives.
By leveraging advanced AI technologies, Roche is accelerating drug discovery, optimizing patient outcomes, and driving efficiency across the pharmaceutical sector. This commitment to AI-powered innovation ensures that the company remains at the cutting edge of the industry.
